CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3027% below fair value
$48.01−0.38 (-0.79%)
Close on Nov 18, 2026Market cap $1.43BP/E 19.8Yield 1.25%
Conmed operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Conmed's operating cash flow for the twelve months ending Sep 30, 2026 was $146.31M, down 12.7% year over year. For fiscal 2025 it was $170.69M, up 2.2% from the year before. Over ten years it grew 12.9% a year on average. The highest annual figure on record is $170.69M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $170.69M | +2.2% |
| FY2024 | Dec 31, 2024 | $166.97M | +33.2% |
| FY2023 | Dec 31, 2023 | $125.35M | +275.7% |
| FY2022 | Dec 31, 2022 | $33.37M | -70.1% |
| FY2021 | Dec 31, 2021 | $111.77M | +73.2% |
| FY2020 | Dec 31, 2020 | $64.53M | -32.2% |
| FY2019 | Dec 31, 2019 | $95.13M | +27.4% |
| FY2018 | Dec 31, 2018 | $74.70M | +13.9% |
| FY2017 | Dec 31, 2017 | $65.57M | +64.4% |
| FY2016 | Dec 31, 2016 | $39.88M | -21.7% |
| FY2015 | Dec 31, 2015 | $50.92M | -21.9% |
| FY2014 | Dec 31, 2014 | $65.18M | -19.5% |
| FY2013 | Dec 31, 2013 | $80.95M | -15.0% |
| FY2012 | Dec 31, 2012 | $95.20M | -7.6% |
| FY2011 | Dec 31, 2011 | $102.99M | +169.3% |
| FY2010 | Dec 31, 2010 | $38.24M | +52.8% |
| FY2009 | Dec 31, 2009 | $25.03M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $49.41M | -8.0% |
| Q2 FY2026 | Jun 30, 2026 | $37.10M | +27.3% |
| Q1 FY2026 | Mar 31, 2026 | $13.47M | -67.6% |
| Q4 FY2025 | Dec 31, 2025 | $46.34M | +6.9% |
| Q3 FY2025 | Sep 30, 2025 | $53.69M | +4.8% |
| Q2 FY2025 | Jun 30, 2025 | $29.13M | -32.7% |
| Q1 FY2025 | Mar 31, 2025 | $41.53M | +42.6% |
| Q4 FY2024 | Dec 31, 2024 | $43.34M | -23.2% |
| Q3 FY2024 | Sep 30, 2024 | $51.20M | +11.0% |
| Q2 FY2024 | Jun 30, 2024 | $43.31M | +62.4% |
| Q1 FY2024 | Mar 31, 2024 | $29.12M | – |
| Q4 FY2023 | Dec 31, 2023 | $56.40M | – |
| Q3 FY2023 | Sep 30, 2023 | $46.13M | +78.1% |
| Q2 FY2023 | Jun 30, 2023 | $26.67M | +42.3% |
| Q1 FY2023 | Mar 31, 2023 | -$3.85M | -1272.9% |
| Q4 FY2022 | Dec 31, 2022 | -$11.60M | -134.3% |
| Q3 FY2022 | Sep 30, 2022 | $25.89M | +21.2% |
| Q2 FY2022 | Jun 30, 2022 | $18.74M | -45.3% |
| Q1 FY2022 | Mar 31, 2022 | $328.00K | -98.5% |
| Q4 FY2021 | Dec 31, 2021 | $33.79M | +67.7% |
| Q3 FY2021 | Sep 30, 2021 | $21.36M | -39.2% |
| Q2 FY2021 | Jun 30, 2021 | $34.28M | +518.9% |
| Q1 FY2021 | Mar 31, 2021 | $22.34M | +500.5% |
| Q4 FY2020 | Dec 31, 2020 | $20.15M | -50.7% |
| Q3 FY2020 | Sep 30, 2020 | $35.13M | -4.0% |
| Q2 FY2020 | Jun 30, 2020 | $5.54M | -74.3% |
| Q1 FY2020 | Mar 31, 2020 | $3.72M | – |
| Q4 FY2019 | Dec 31, 2019 | $40.88M | +65.5% |
| Q3 FY2019 | Sep 30, 2019 | $36.60M | +741.2% |
| Q2 FY2019 | Jun 30, 2019 | $21.58M | +4.6% |
| Q1 FY2019 | Mar 31, 2019 | -$3.92M | -115.7% |
| Q4 FY2018 | Dec 31, 2018 | $24.70M | +18.7% |
| Q3 FY2018 | Sep 30, 2018 | $4.35M | -67.6% |
| Q2 FY2018 | Jun 30, 2018 | $20.63M | +28.7% |
| Q1 FY2018 | Mar 31, 2018 | $25.02M | +63.6% |
| Q4 FY2017 | Dec 31, 2017 | $20.81M | +52.0% |
| Q3 FY2017 | Sep 30, 2017 | $13.43M | – |
| Q2 FY2017 | Jun 30, 2017 | $16.03M | – |
| Q1 FY2017 | Mar 31, 2017 | $15.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $13.69M | – |
See a number that looks wrong?